Learn More
Description
Specifications
Specifications
| For Use With (Application) | Bioactivity |
| Formulation | Lyophilized from a 0.2 μm filtered solution in MOPS, Na2SO4 and EDTA with Trehalose. |
| Gene ID (Entrez) | 2249 |
| Molecular Weight (g/mol) | 12 to 15 kDa, under reducing conditions |
| Quantity | 1 mg |
| Source | E. coli-derived human FGF-4 protein Proprietary, engineered based on P08620 |
| Storage Requirements | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution. |
| Endotoxin Concentration | <0.10 EU per 1 μg of the protein by the LAL method. |
| Gene Alias | FGF4, fibroblast growth factor 4, HBGF-4, HBGF-4Transforming protein KS3, heparin secretory transforming protein 1, Heparin secretory-transforming protein 1, Heparin-binding growth factor 4, HST-1, HST-1HSTF-1, HSTF1fibroblast growth factor 4 splice isoform, HSTFGF-4, human stomach cancer, transforming factor from FGF-related oncogene, kaposi sarcoma oncogene, KFGF, K-FGF, KS3, oncogene HST |
| Conjugate | Unconjugated |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
